172 related articles for article (PubMed ID: 30140383)
1. High AGR2 protein is a feature of low grade endometrial cancer cells.
Kamal A; Valentijn A; Barraclough R; Rudland P; Rahmatalla N; Martin-Hirsch P; Stringfellow H; Decruze SB; Hapangama DK
Oncotarget; 2018 Jul; 9(59):31459-31472. PubMed ID: 30140383
[TBL] [Abstract][Full Text] [Related]
2. Anterior Gradient 2 is a Poor Outcome Indicator in Luminal Breast Cancer.
Lacambra MD; Tsang JY; Ni YB; Chan SK; Tan PH; Tse GM
Ann Surg Oncol; 2015 Oct; 22(11):3489-96. PubMed ID: 25663596
[TBL] [Abstract][Full Text] [Related]
3. Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients.
Innes HE; Liu D; Barraclough R; Davies MP; O'Neill PA; Platt-Higgins A; de Silva Rudland S; Sibson DR; Rudland PS
Br J Cancer; 2006 Apr; 94(7):1057-65. PubMed ID: 16598187
[TBL] [Abstract][Full Text] [Related]
4. [Expression of a novel metastasis-inducing protein human anterior gradient-2 (AGR2) in breast cancer and its clinical and prognostic significance].
Wu ZS; Wu Q; Ding XD; Wang HQ; Shen YX; Fang SY
Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):109-13. PubMed ID: 18681322
[TBL] [Abstract][Full Text] [Related]
5. Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma.
Darb-Esfahani S; Fritzsche F; Kristiansen G; Weichert W; Sehouli J; Braicu I; Dietel M; Denkert C
Virchows Arch; 2012 Aug; 461(2):109-16. PubMed ID: 22752467
[TBL] [Abstract][Full Text] [Related]
6. The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker.
Salmans ML; Zhao F; Andersen B
Breast Cancer Res; 2013 Apr; 15(2):204. PubMed ID: 23635006
[TBL] [Abstract][Full Text] [Related]
7. The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.
Bu H; Bormann S; Schäfer G; Horninger W; Massoner P; Neeb A; Lakshmanan VK; Maddalo D; Nestl A; Sültmann H; Cato AC; Klocker H
Prostate; 2011 May; 71(6):575-87. PubMed ID: 20945500
[TBL] [Abstract][Full Text] [Related]
8. Fallopian tube epithelial cells express androgen receptor and have a distinct hormonal responsiveness when compared with endometrial epithelium.
Maclean A; Bunni E; Makrydima S; Withington A; Kamal AM; Valentijn AJ; Hapangama DK
Hum Reprod; 2020 Sep; 35(9):2097-2106. PubMed ID: 32876325
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor as potential therapeutic target in metastatic endometrial cancer.
Tangen IL; Onyango TB; Kopperud R; Berg A; Halle MK; Øyan AM; Werner HM; Trovik J; Kalland KH; Salvesen HB; Krakstad C
Oncotarget; 2016 Aug; 7(31):49289-49298. PubMed ID: 27384477
[TBL] [Abstract][Full Text] [Related]
10. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha.
Collins F; MacPherson S; Brown P; Bombail V; Williams AR; Anderson RA; Jabbour HN; Saunders PT
BMC Cancer; 2009 Sep; 9():330. PubMed ID: 19758455
[TBL] [Abstract][Full Text] [Related]
11. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
[TBL] [Abstract][Full Text] [Related]
12. AGR2 is associated with gastric cancer progression and poor survival.
Zhang J; Jin Y; Xu S; Zheng J; Zhang QI; Wang Y; Chen J; Huang Y; He X; Zhao Z
Oncol Lett; 2016 Mar; 11(3):2075-2083. PubMed ID: 26998125
[TBL] [Abstract][Full Text] [Related]
13. Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype.
Kani K; Malihi PD; Jiang Y; Wang H; Wang Y; Ruderman DL; Agus DB; Mallick P; Gross ME
Prostate; 2013 Feb; 73(3):306-15. PubMed ID: 22911164
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer.
Valladares-Ayerbes M; Blanco-Calvo M; Reboredo M; Lorenzo-Patiño MJ; Iglesias-Díaz P; Haz M; Díaz-Prado S; Medina V; Santamarina I; Pértega S; Figueroa A; Antón-Aparicio LM
Int J Mol Sci; 2012; 13(4):4367-4387. PubMed ID: 22605983
[TBL] [Abstract][Full Text] [Related]
15. AGR2 diagnostic value in nasopharyngeal carcinoma prognosis.
Li Y; Wang W; Liu Z; Jiang Y; Lu J; Xie H; Tang F
Clin Chim Acta; 2018 Sep; 484():323-327. PubMed ID: 29269202
[TBL] [Abstract][Full Text] [Related]
16. The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients.
Barraclough DL; Platt-Higgins A; de Silva Rudland S; Barraclough R; Winstanley J; West CR; Rudland PS
Am J Pathol; 2009 Nov; 175(5):1848-57. PubMed ID: 19834055
[TBL] [Abstract][Full Text] [Related]
17. AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer.
Zhang JS; Gong A; Cheville JC; Smith DI; Young CY
Genes Chromosomes Cancer; 2005 Jul; 43(3):249-59. PubMed ID: 15834940
[TBL] [Abstract][Full Text] [Related]
18. Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma.
Hu G; Zhang J; Zhou X; Liu J; Wang Q; Zhang B
Pathol Res Pract; 2020 Oct; 216(10):153149. PubMed ID: 32853964
[TBL] [Abstract][Full Text] [Related]
19. AGR2 associates with HER2 expression predicting poor outcome in subset of estrogen receptor negative breast cancer patients.
Ondrouskova E; Sommerova L; Nenutil R; Coufal O; Bouchal P; Vojtesek B; Hrstka R
Exp Mol Pathol; 2017 Apr; 102(2):280-283. PubMed ID: 28238761
[TBL] [Abstract][Full Text] [Related]
20. Associations of MACC1, AGR2, and KAI1 expression with the metastasis and prognosis in head and neck squamous cell carcinoma.
Sun B; Cheng Z; Sun J
Int J Clin Exp Pathol; 2018; 11(2):822-830. PubMed ID: 31938171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
